在各市场之间对比单一化妆品物质
输入一个 INCI 名称、化学名称、CAS 或 EC 编号。该工具将欧盟附件证据、关联的成分身份和独立的官方国家记录合并为一份对比。
缺少本地记录会显示为证据缺口,绝不视为准许或安全性结论。
搜索确切身份
对比查询
85135-77-9
在 13 个市场数据集中的 3 个找到了匹配的监管证据。
有证据的市场
3
证据缺口
10
国家记录
3
欧盟附件记录
0
已解析的身份证据
CAS:85135-77-916083-14-03349-08-439819-65-318721-51-218283-82-422605-92-14454-16-47580-31-693983-68-729317-63-327637-46-384852-37-993920-10-685508-43-685508-44-751818-56-593920-09-371957-07-852625-25-913654-40-585508-45-885508-46-984852-35-784852-39-185166-19-484852-36-885551-28-691697-41-584776-45-472319-19-87757-95-115851-52-215852-21-868130-36-9
3 个匹配或报告的名称
(2-Ethylhexanoato-O)(neodecanoato-O)nickel [25](Isononanoato-O)(neodecanoato-O)nickel [28] Fatty acids, C6-19-branched, nickel salts [29] Fatty acids, C8-18 and C18-unsaturated, nickel salts [30] 2,7-Naphthalenedisulfonic acid, nickel(II) salt [31] (CAS No. 16083-14-0 [1], 3349-08-4 [2], 39819-65-3 [3], 18721-51-2 [4], 18283-82-4 [5], 22605-92-1 [6], 4454-16-4 [7], 7580-31-6 [8], 93983-68-7 [9], 29317-63-3 [10], 27637-46-3 [11], 84852-37-9 [12], 93920-10-6 [13], 85508-43-6 [14], 85508-44-7 [15], 51818-56-5 [16], 93920-09-3 [17], 71957-07-8 [18], 52625-25-9 [19], 13654-40-5 [20], 85508-45-8 [21], 85508-46-9 [22], 84852-35-7 [23], 84852-39-1 [24], 85135-77-9 [25], 85166-19-4 [26], 84852-36-8 [27], 85551-28-6 [28], 91697-41-5 [29], 84776-45-4 [30], 72319-19-8 [31]) Nickel(II) sulfite [1], Nickel tellurium trioxide [2], Nickel tellurium tetraoxide [3], Molybdenum nickel hydroxide oxide phosphate [4] (CAS No. 7757-95-1 [1], 15851-52-2 [2], 15852-21-8 [3], 68130-36-9Nickel(II) trifluoroacetate; [1] Nickel(II) propionate; [2] Nickel bis(benzenesulfonate); [3] Nickel(II) hydrogen citrate; [4] Citric acid, ammonium nickel salt; [5] Citric acid, nickel salt; [6] Nickel bis(2-ethylhexanoate); [7] 2-Ethylhexanoic acid, Nickel salt; [8] Dimethylhexanoic acid nickel salt; [9] Nickel(II) isooctanoate; [10] Nickel isooctanoate; [11] Nickel bis(isononanoate); [12] Nickel(II) neononanoate; [13] Nickel(II) isodecanoate; [14] Nickel(II) neodecanoate; [15] Neodecanoic acid, nickel salt; [16] Nickel(II) neoundecanoate; [17] Bis(D-gluconato-O1,O2)nickel; [18] Nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19] Nickel(II) palmitate; [20] (2-Ethylhexanoato-O)(Isononanoato-O)nickel; [21] (Isononanoato-O)(Isooctanoato-O)nickel; [22] (Isooctanoato-O)(neodecanoato-O)nickel; [23] (2-Ethylhexanoato-O)(Isodecanoato-O)nickel; [24] (2-Ethylhexanoato-O)(Neodecanoato-O)nickel; [25] (Isodecanoato-O)(isooctanoato-O)nickel; [26] (Isodecanoato-O)(isononanoato-O)nickel; [27] (Isononanoato-O)(Neodecanoato-O)nickel; [28] fatty acids, C6-19-branched, nickel salts; [29] fatty acids, C8-18 and C18-unsaturated, nickel salts; [30] 2,7-Naphthalenedisulfonic acid, nickel(II) salt; [31]
按市场划分的监管证据
状态为我们数据集中最强的匹配记录。请打开记录查看确切条件和法律范围。
| 市场 | 结果 | 记录 | 数据集覆盖范围 | 后续操作 |
|---|---|---|---|---|
| European Union EU | 未找到匹配项 | 0 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review. |
| Great Britain GB | 未找到匹配项 | 0 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework. |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Prohibited | 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | 请查看每条匹配记录及其条件。 |
| ASEAN ASEAN | 未找到匹配项 | 0 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Regional annex coverage does not replace member-state implementation dates, notifications or national deviations. |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | 未找到匹配项 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | 未找到匹配项 | 0 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Korean source wording is canonical and other positive lists/notices may still apply to the formulation. |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Prohibited | 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | 请查看每条匹配记录及其条件。 |
| Saudi Arabia SA | Prohibited | 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | 请查看每条匹配记录及其条件。 |
没有与此筛选条件匹配的市场行。
匹配的记录和条件
完成官方核实工作流程
成分证据只是其中一层。这些针对特定市场的步骤列出了作出合规决定之前仍需完成的核查。
European Union · Complete annex dataset
- Confirm the exact INCI/CAS/EC identity.
- Review every matching Annex II–VI row and its conditions.
- Check SCCS opinions, CMR/nanomaterial rules and later amendments.
- Verify product classification, claims, labelling and responsible-person duties.
Great Britain · Complete consolidated annex dataset
- Confirm INCI/CAS/EC identity.
- Review every current GB Annex II–VI match.
- Check commencement dates and later statutory instruments.
- Verify SCPN, responsible-person, safety-report and labelling duties.
Canada · Complete Hotlist snapshot
- Search English/French names and CAS identifiers.
- Apply every restriction, concentration and label warning.
- Check Food and Drugs Act/Cosmetic Regulations requirements.
- Recheck the current Hotlist before notification or sale.
New Zealand · Complete schedules dataset
- Search exact identity across Schedules 4–8.
- Apply use, concentration and warning conditions.
- Check hazardous-substance classification and Group Standard scope.
- Confirm the latest legal instrument, not only the spreadsheet.
ASEAN · Complete regional annex dataset
- Search all ACD annexes by name and identifiers.
- Apply product type, maximum level and warning conditions.
- Confirm the target member state's adoption and transition date.
- Complete the local notification and responsible-company requirements.
China · Complete prohibited catalogues plus official-source workflow
- Search the current NMPA IECIC List I and List II by Chinese name and identity.
- Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
- Review technical purpose, use history and any monitoring period.
- Confirm Chinese labelling, safety assessment and filing/registration duties.
Japan · Complete Standards appendices dataset
- Search Japanese/English identity and CAS where present.
- Apply category and maximum-amount conditions.
- Check later MHLW notices against the Japanese source.
- Verify marketing licence, notification, labelling and quasi-drug classification.
South Korea · Complete current appendix dataset
- Match the Korean canonical substance name and identifiers.
- Review all Appendix 1 and 2 matches and conditions.
- Check functional-cosmetic and positive-list requirements where applicable.
- Confirm current MFDS notice, responsible seller and label obligations.
United States · Complete enumerated federal ingredient rules
- Search Part 700 and all relevant colour-additive parts.
- Confirm colour additive identity, permitted uses, limits and certification status.
- Assess safety and adulteration under the FD&C Act.
- Complete MoCRA facility/product, adverse-event and label obligations where applicable.
Australia · Complete cosmetic-relevant Poisons Standard subset plus official workflow
- Decide whether the product is a cosmetic or therapeutic good.
- Check the current Poisons Standard for every ingredient.
- Search AICIS Inventory terms and assessment certificates by exact identity.
- Determine introduction category, registration, reporting, records and labelling duties.
Brazil · Complete prohibited dataset plus current restricted-list workflow
- Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
- Check the consolidated prohibited list including RDC 1.030/2026 changes.
- Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
- Verify Mercosur incorporation, regularisation, labelling and transition periods.
India · Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
- Confirm product class and current Cosmetics Rules/gazette amendments.
- Check all applicable parts of IS 4707 by exact identity.
- Apply Schedule S/other finished-product standards where relevant.
- Verify licence/import registration, labelling and testing requirements.
Saudi Arabia · Complete official list index
- Search names and CAS across both SFDA lists.
- Open the cited restricted-entry detail and apply every condition.
- Check current SFDA/GSO technical regulations and updates.
- Complete eCosma notification, label and responsible-party requirements.
本对比能够和不能决定什么
1. 解析身份
CAS 和 EC 标记会被精确提取。名称搜索使用规范化的官方名称和关联的身份。
2. 对比证据
针对每个受支持的市场,分别显示最强的匹配状态和直接记录。
3. 完成核实
产品类型、浓度、纯度、警示语、宣称、分类及后续修订仍需官方审核。